What is Metixen used for?

Metixen is indicated for Parkinsonism.

Metixen is developed by Novartis.

What development phase is Metixen in?

Metixen is FDA-approved (marketed).

What is the generic name of Metixen?

metixene is the generic (nonproprietary) name of Metixen.

Last reviewed 2026-04-20 · How we verify

Metixen (metixene)

Novartis · FDA-approved active Quality 17/100

At a glance

Generic name	metixene
Sponsor	Novartis
Drug class	metixene
Target	5-hydroxytryptamine receptor 2C
Therapeutic area	Neuroscience
Phase	FDA-approved

Approved indications

Parkinsonism

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Metixen CI brief — competitive landscape report
Metixen updates RSS · CI watch RSS
Novartis portfolio CI